The prognosis of patients with lung cancer is related to the stage of the diagnosis : 73% of one-year-survival rate at stage IA and only 13% one-year-survival rate at stage IV. Controlling the timelines in a care program seems crucial to improve prognosis of lung cancer. The project aims to evaluate the impact of a coordinating nurse (CN) in a personalized care program for patients of thoracic oncology.
New strategies therapeutics result in a longer survival rate. However their side effects affect the patient's quality of life. Even if these side effects are ambulatory manageable, they require to be treated promptly and tends to increase the active list of patients of the thoracic oncology. Due to the alteration in the care provided to lung cancer patient, there is a need to coordinate the available means, inside and outside the hospital, to improve the quality of care and the quality of life of the patient. Every patient of the thoracic oncology department receives a personalized care program as a routine practice. In this study, a coordinating nurse (CN) will be added to the personalized care program. Patients newly diagnosed with a lung cancer will be randomized either in the group with a CN or in the group without a CN. The study will last one year maximum for each participant. Their quality of life, their satisfaction of the quality of the personalized care program - and their general practitioner's satisfaction - will be evaluated throughout the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
59
Questionnaire submitted at the beginning of the study. Then three more times : 3, 6 and 12 months after the start of anti-cancer therapy. The questionnaire can also be completed before the 12th month: when the care program is about to end
The patient will fill in a satisfaction questionnaire three times : around the third, the sixth and the twelfth month after they started an anti-cancer therapy.
The general practitioner or the nurse in charge of the patient at home will fill in a satisfaction questionnaire six months after the patient started an anti-cancer therapy.
Questionnaire submitted at the beginning of the study. Then three more times : 3, 6 and 12 months after the start of anti-cancer therapy. The questionnaire can also be completed before the 12th month: when the care program is about to end
GHRMSA
Mulhouse, France
Impact of the coordinating nurse on quality of care measured by the variation of timelines in personalized care
Variation of the time between the first appointment with the thoracic oncologist and the first day of anticancer therapy
Time frame: At visit 1, around 1 month after the beginning of the study
Analysis of the feedback from healthcare professionals outside the thoracic oncology ward
Measured by satisfaction questionnaires submitted to general practitioner or home nurse
Time frame: 6 months after the beginning of the study
Impact of a coordinating nurse in a personalized care program on the patient's quality of life
Evolution of the scoring results of the EORTC QLQ-C30
Time frame: At the beginning of the study, then around 3, around 6 and around 12 months later
Impact of a coordinating nurse in a personalized care program on the patient's quality of life
Evolution of the scoring results of the EORTC QLQ-LC13
Time frame: At study enrollment, then around 3 and around 6 and around 12 months later
Analysis of the feedback from the patient
Measured by satisfaction questionnaires submitted to the patient
Time frame: Around 3 and around 6 and around 12 months after beginning of study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.